We are live on ! Find out more
CCM

Chiron Capital Management Portfolio holdings

AUM $111M
This Fund
S&P 500
This Quarter Est. Return
+10.08%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$121M
AUM Growth
-$2.71M
Cap. Flow
-$12.4M
Cap. Flow %
-10.18%
Top 10 Hldgs %
66.14%
Holding
517
New
1
Increased
22
Reduced
44
Closed
435

Sector Composition

Rank Sector Weight
1 Healthcare 52.33%
2 Consumer Staples 6.59%
3 Energy 5.79%
4 Technology 5.35%
5 Financials 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APA icon
101
APA Corp
APA
$12.9B
-300
Closed -$3K
APPN icon
102
Appian
APPN
$2.23B
-171
Closed -$11K
AQB icon
103
AquaBounty Technologies
AQB
$5.51M
-1
Closed
ARCC icon
104
Ares Capital
ARCC
$14.1B
-100
Closed -$1K
ARKK icon
105
ARK Innovation ETF
ARKK
$6.01B
-119
Closed -$11K
ARWR icon
106
Arrowhead Research
ARWR
$12.1B
-1,500
Closed -$65K
ATI icon
107
ATI
ATI
$30.5B
-800
Closed -$7K
AUPH icon
108
Aurinia Pharmaceuticals
AUPH
$2.07B
-9,700
Closed -$143K
AVNS
109
DELISTED
Avanos Medical
AVNS
-31
Closed -$1K
AVTX icon
110
Avalo Therapeutics
AVTX
$989M
0
AXP icon
111
American Express
AXP
$231B
-550
Closed -$55K
AZN icon
112
AstraZeneca
AZN
$250B
-50
Closed -$5K
BABA icon
113
Alibaba
BABA
$304B
-605
Closed -$178K
BBDC icon
114
Barings BDC
BBDC
$963M
-500
Closed -$4K
BBWI icon
115
Bath & Body Works
BBWI
$4.06B
-1,361
Closed -$35K
BCE icon
116
BCE
BCE
$21.2B
-100
Closed -$4K
BFH icon
117
Bread Financial
BFH
$4.44B
-376
Closed -$13K
BHF icon
118
Brighthouse Financial
BHF
$3.57B
-33
Closed -$1K
BKR icon
119
Baker Hughes
BKR
$62.3B
-2,000
Closed -$27K
BLUE
120
DELISTED
bluebird bio
BLUE
-8
Closed -$5K
BME icon
121
BlackRock Health Sciences Trust
BME
$562M
-766
Closed -$33K
BMO icon
122
Bank of Montreal
BMO
$127B
-100
Closed -$6K
BMRN icon
123
BioMarin Pharmaceuticals
BMRN
$11.9B
-1,950
Closed -$148K
BMY icon
124
CALL
Bristol-Myers Squibb
BMY
$131B
-200
Closed -$2K
BMY icon
125
PUT
Bristol-Myers Squibb
BMY
$131B
-2,100
Closed -$6K

Similar funds

Chiron Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Chiron Capital Management held 517 positions worth $121M, down 2.2% from $124M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Chiron Capital Management withdrew a net $12.4M in Q4 2020, closing 435 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $312K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 53% a quarter earlier, followed by Consumer Staples and Energy.

Against the trend, Chiron Capital Management opened a new position in Viatris worth $312K.

  • Chiron Capital Management's largest Q4 2020 buy was Viatris: 16,662 shares worth $312K.
  • Chiron Capital Management added most to Intel in Q4 2020, an estimated $2.5M increase.
  • Chiron Capital Management's biggest Q4 2020 reduction was Capital One, cutting an estimated $910K.
  • Chiron Capital Management fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $312K.
  • Chiron Capital Management's ten largest holdings make up 66% of its $121M portfolio in Q4 2020.
  • Chiron Capital Management opened 1 new position and closed 435 in Q4 2020.
  • Chiron Capital Management's portfolio value fell 2.2% quarter-over-quarter to $121M.

Based on Chiron Capital Management's 13F filing for Q4 2020, filed 5 Mar 2021.